Back
Amicus Therapeutics Stock Predictions
Sponsored
FOLD
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29
FOLD
Amicus Therapeutics
Last Price:
9.68
Seasonality Move:
7.75%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Amicus Therapeutics Stock Forecast
- Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 12.7% based on the past 17 years of stock performance.
- Amicus Therapeutics has risen higher in 6 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 35.29%
-
Is Amicus Therapeutics Stock Undervalued?
The current Amicus Therapeutics [FOLD] share price is $9.66. The Score for FOLD is 29, which is 42% below its historic median score of 50, and infers higher risk than normal. - FOLD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Amicus Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 12.7% based on the past 17 years of stock performance.
Amicus Therapeutics Stock Rating
Sell
29
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics overpriced?
- Amicus Therapeutics has risen higher in 6 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 35.29%
Amicus Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com
52-Week Data
52-Week High:
14.57
52-Week Low:
9.02
Prediction Charts
Market Cap:
2.89B
Price in USD:
9.66
Volume:
1.92M
Beta:
1.02
Technical Analysis
SMA50:
10.81
SMA100:
10.86
SMA200:
10.98
52-Wk Change:
-9.21%
Stock Predictions
-
Is Amicus Therapeutics stock public?
Yes, Amicus Therapeutics is a publicly traded company. -
What is the Amicus Therapeutics stock quote today?
The Amicus Therapeutics stock price is 9.66 USD today. -
How to buy Amicus Therapeutics stock online?
You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-5 | 11.24 | 11.74 | 11.75 | 11.21 |
Nov-6 | 12.53 | 11.23 | 12.65 | 10.92 |
Nov-7 | 11.24 | 10.97 | 11.25 | 10.73 |
Nov-8 | 11.00 | 10.99 | 11.36 | 10.94 |
Nov-11 | 11.09 | 10.69 | 11.14 | 10.66 |
Nov-12 | 10.69 | 10.49 | 10.83 | 10.43 |
Nov-13 | 10.57 | 10.38 | 10.66 | 10.30 |
Nov-14 | 10.38 | 10.09 | 10.43 | 10.06 |
Nov-15 | 10.13 | 9.68 | 10.13 | 9.64 |
Nov-18 | 9.93 | 9.66 | 10.04 | 9.60 |
Nov-19 | 9.37 | 9.52 | 9.56 | 9.37 |
Nov-20 | 9.49 | 9.59 | 9.68 | 9.38 |
Nov-21 | 9.62 | 9.50 | 9.64 | 9.39 |
Nov-22 | 9.51 | 9.66 | 9.78 | 9.46 |
Amicus Therapeutics Earnings
Amicus Therapeutics Earnings Report: Per Share Amicus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Amicus Therapeutics Forecast Revenue Growth
Amicus Therapeutics Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.21 per share.
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.